Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome reduces effectiveness of hair loss treatment.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Obesity and lifestyle strongly affect heart aging.

Adipose tissue-derived therapies show promise for improving osteoarthritis symptoms but need more research for safety and effectiveness.

Ultrasound is a useful, safe, and affordable tool for diagnosing and managing skin nodules.

Acne is strongly linked to high BMI, hair loss, menstrual issues, family history, and eating too many sweets and fatty foods, but not to excessive hair growth.

Lower adiponectin levels may relate to depression in women with PCOS.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Androgenetic alopecia is linked to higher cholesterol in both sexes and obesity in women.

More research is needed before using brown fat to treat polycystic ovary syndrome.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Lean and obese women with PCOS have similar levels of insulin resistance, indicating it's a core aspect of the condition.

Curcumin supplements increase adiponectin and decrease leptin in adults.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Patients with metabolic syndrome often have skin problems like acanthosis nigricans and skin tags, and early treatment is important to prevent serious issues.

Semaglutide may worsen eating disorders in vulnerable individuals.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

ADSC-CM treatment improved hair density and thickness in women with hair loss, safely and effectively.

Androgenetic alopecia is linked to insulin resistance and hormonal imbalances.

Injecting minced fat into the facial artery can cause severe eye problems and death, more so than other fat types, and larger amounts increase these risks.

Early hair loss may indicate a higher risk of diabetes in young and middle-aged adults.

Fat tissue treatments may help with wound healing and hair growth, but more research with larger groups is needed to be sure.

An unhealthy lifestyle increases the risk of metabolic syndrome.

Adipose-derived stem cells may help treat hair loss.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

Lower ghrelin levels and certain gene variations may increase acne risk.